17.7
Enveric Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
18.4
FY23:
3.58
FY24:
2.73
FY25:
4.94
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.98
FY22:
1.12
FY23:
0.72
FY24:
0.35
FY25:
0.16
Total assets
Change from FY21 to FY25
millions USD
FY21:
26.7
FY22:
19.6
FY23:
4.30
FY24:
3.08
FY25:
5.10
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.74
FY22:
4.00
FY23:
2.34
FY24:
1.49
FY25:
0.92
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.68
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.3
FY22:
14.7
FY23:
1.96
FY24:
1.59
FY25:
4.18
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
26.7
FY22:
18.7
FY23:
4.30
FY24:
3.08
FY25:
5.10
All amounts in millions USD